Skip to main content
SpringerLink
Log in

Kiel Lymphoma Study Group

  • Conference paper
Book cover Lymphoproliferative Diseases of the Skin

  • 68 Accesses

Abstract

Immediately after its publication the Kiel classification of non-Hodgkin lymphomas (NHL) [10,15] attracted the interest not only of pathologists but also of clinicians. In order to analyze its clinical applicability and prognostic value which are considered to be the most crucial points for the practical use of a new histopathologic system, in West Germany and Austria several internists and radiotherapists formed a cooperative multi-center study group. This so-called Kiel Lymphoma Study Group first started a retrospective investigation evaluating data from 405 patients [4, 5, 23]. Encouraging results of this analysis led the same group in 1975 to initiate a more detailed prospective study [3]. After a period of 5 years, in October 1980 when registration of new patients was closed, more than 1000 patients from 20 hospitals had entered the study.

Supported by the Deutsche Krebshilfe e. V., Bonn, and the Deutsche Forschungsgemeinschaft, Bonn-Bad Godesberg, Sonderforschungsbereich 102, Essen

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Bagley CM, DeVita VT, Berard CW, Canellos GP (1972) Advanced lymphosarcoma: Intensive cyclical combination chemotherapy with cyclophosphamide, vincristine and prednisone. Ann Intern Med 76: 227–234

    PubMed  Google Scholar 

  2. Bonadonna G, De Lena M, Lattuada A, Milani F, Monfardini S, Beretta G (1975) Combination chemotherapy and radiotherapy in non-Hodgkin’s lymphomata. Br J Cancer [Suppl II] 31: 481–488

    Google Scholar 

  3. Brittinger G (1978) Outline of a prospective multicentric study on the clinical significance of the Kiel classification of non-Hodgkin’s lymphomas. Recent Results Cancer Res 65: 195–199

    Google Scholar 

  4. Brittinger G, Bartels H, Bremer K, Dühmke E, Gunzer U, König E, Stein H (1976) Klinik der malignen Non-Hodgkin-Lymphome entsprechend der Kiel-Klassifikation: Centrocytisches Lymphom, centroblastisch-centrocytisches Lymphom, lymphoblastisches Lymphom, immuno- blastisches Lymphom. In: Löffler H (ed) Maligne Lymphome und monoklonale Gammopathien. Haematol Bluttransfus 18: 211–223

    Google Scholar 

  5. Brittinger G, Battels H, Bremer K, Burger A, Dühmke E, Gunzer U et al. (1977) Retrospektive Untersuchungen zur klinischen Bedeutung der Kiel-Klassifikation der malignen Non-Hodgkin-Lymphome. Strahlentherapie 153: 222–228

    PubMed  CAS  Google Scholar 

  6. Brittinger G, Schmalhorst U, Bartels H, Bremer K, Brunswicker F, Burger A et al. (Kiel Lymphoma Study Group) (1979) Chemotherapy of non-Hodgkin’s lymphomas — Indications and results. In: Crowther DG (ed) Leukemia and non-Hodgkin Lymphoma. Pergamon Press, Oxford New York Toronto Sydney Paris Frankfurt: Advances in Medical Oncology, Research and Education, vol VII, pp 229–241

    Google Scholar 

  7. Brittinger G, Schmalhorst U, Bartels H, Fülle HH, Gerhartz H, Gremmel H, et al. (Kiel Lymphoma Study Group) (to be published) Principles and present status of a prospective multicenter study on the clinical relevance of the Kiel classification. Blut

    Google Scholar 

  8. Carbone PP, Kaplan HS, Musshoff K, Smithers DW, Tubiana M (1971) Report of the committee on Hodgkin’s disease staging classification. Cancer Res 31: 1860–1861

    PubMed  CAS  Google Scholar 

  9. DeVita VT jr, Serpick A, Carbone PP (1970) Combination chemotherapy in the treatment of advanced Hodgkin’s disease. Ann Intern Med 73: 881–895

    PubMed  Google Scholar 

  10. Gerard-Marchant R, Hamlin I, Lennert K, Rilke F, Stansfeld AG, van Unnik JAM (1974) Classification of non-Hodgkin’s lymphomas. Lancet II: 406–408

    Google Scholar 

  11. Han T, Ezdinli EZ, Shimaoka K, Desai DV (1973) Chlorambucil vs combined chlorambucil-corticosteroid therapy in chronic lymphocytic leukemia. Cancer 31: 502–508

    Article  PubMed  CAS  Google Scholar 

  12. Heinz R, Stacher A, Pralle H, Theml H, Brunswicker F, Burkert M, et al. (Kiel Lymphoma Study Group) (to be published) Lymphoplasmacytic/lymphoplasmacytoid lymphoma: A clinical entity distinct from chronic lymphocytic leukaemia? Blut

    Google Scholar 

  13. Knospe WH, Loeb V jr, Huguley CM jr (1974) Bi-weekly chlorambucil treatment of chronic lymphocytic leukemia. Cancer 33: 555–562

    Article  PubMed  CAS  Google Scholar 

  14. König E, Bartels H, Bremer K, Burger- Schüler A, Common H, Dühmke E, Engelhard M, et al. (Kiel Lymphoma Study Group) (to be published) Germinal center cell lymphomas: Prognostic significance of their histopathological differentiation. Blut

    Google Scholar 

  15. Lennert K (1978) Malignant lymphomas other than Hodgkin’s disease. In: Uehlinger E (ed) Lymphknoten, Diagnostik in Schnitt und Ausstrich. Springer, Berlin Heidelberg New York (Handbuch der speziellen pathologischen Anatomie und Histologic, vol 1, part 3B )

    Google Scholar 

  16. McKelvey EM, Gottlieb JA, Wilson HE, Haut A, Talley RW, Stephens R, et al. (1976) Hydroxyldaunomycin (adriamycin) combination chemotherapy in malignant lymphoma. Cancer 38: 1484–1493

    Article  PubMed  CAS  Google Scholar 

  17. Meusers P, Bartels H, Brittinger G, Common H, Dühmke E, Fülle HH, Gunzer U, et al. (Kiel Lymphoma Study Group) (1979) Heterogeneity of diffuse “histiocytic” lymphoma according to the Kiel classification. N Engl J Med 301: 384

    PubMed  CAS  Google Scholar 

  18. Musshoff K, Schmidt-Vollmer H (1975) Prognosis of non-Hodgkin’s lymphomas with special emphasis on the staging classification. Z Krebsforsch 83: 323–341

    Article  CAS  Google Scholar 

  19. Portlock CS, Rosenberg SA (1977) Chemotherapy of the non-Hodgkin’s lymphomas: The Stanford experience. Cancer Treat Rep 61: 1049–1055

    PubMed  CAS  Google Scholar 

  20. Rosenberg SA (1979) Non-Hodgkin’s lymphoma — Selection of treatment on the basis of histologic type. N Engl J Med 301: 924–928

    Article  PubMed  CAS  Google Scholar 

  21. Rosenberg SA, Kaplan HS (1975) Clinical trials in the non-Hodgkin’s lymphomata at Stanford University. Experimental design and preliminary results. Br J Cancer [Suppl II] 31: 456–464

    Google Scholar 

  22. Schmalhorst U, Bartels H, Boll I, Burger-Schüler A, Common H, Fülle HH, Graubner M, et al. (Kiel Lymphoma Study Group) (to be published) Clinical and prognostic heterogeneity of non-Hodgkin lymphomas of high-grade malignancy. Blut

    Google Scholar 

  23. Stacher A, Waldner R, Theml H (1976) Klinik der malignen Non-Hodgkin-Lymphome entsprechend der Kieler Klassifikation: Lymphoplasmozytoides Lymphom (LPL) and chronisch lymphatische Leukämie (CLL). Hämatol Bluttransfus 18: 199–209

    Google Scholar 

Download references

Authors
  1. G. Brittinger
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Universitäts-Hautklinik, Schittenhelmstraße 7, D-2300, Kiel, Federal Republic of Germany

    Manfred Goos  & Enno Christophers  & 

Rights and permissions

Reprints and permissions

Copyright information

© 1982 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Brittinger, G. (1982). Kiel Lymphoma Study Group. In: Goos, M., Christophers, E. (eds) Lymphoproliferative Diseases of the Skin. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-68363-3_31

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-68363-3_31

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-11222-8

  • Online ISBN: 978-3-642-68363-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation